Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2009
10/06/2009CA2378469C An oral solid composition comprising carbidopa, levodopa and entacapone
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009121065A2 Modulation and repletion/enhancement of the complement system for treatment of trauma
10/01/2009WO2009121039A2 Administration of benzodiazepine compositions
10/01/2009WO2009120815A2 Therapeutic compositions and methods
10/01/2009WO2009120810A2 Neurodegenerative disorders
10/01/2009WO2009120735A1 Composition and method for transmucosal delivery of lofexidine
10/01/2009WO2009120720A1 Bridged heterocyclic compounds and methods of use
10/01/2009WO2009120717A2 Pyrido [3, 4-b] indoles and methods of use
10/01/2009WO2009120659A2 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents
10/01/2009WO2009120657A2 Human monoclonal antibodies against amyloid beta protein, and their use as therapeutic agents
10/01/2009WO2009120648A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
10/01/2009WO2009120580A2 Methods for preventing or treating bruxism using dopaminergic
10/01/2009WO2009120484A2 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin
10/01/2009WO2009120390A2 Cyclopropanated carbohydrates
10/01/2009WO2009120371A2 Computationally designed inhibitors of amyloidosis
10/01/2009WO2009120368A2 Treatment of brain damage using umbilical cord blood cells
10/01/2009WO2009120300A2 Method of treating degenerative diseases
10/01/2009WO2009120192A2 Process for the preparation of benzo-fused heteroaryl derivatives
10/01/2009WO2009120191A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide
10/01/2009WO2009120189A1 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety
10/01/2009WO2009120140A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives 258
10/01/2009WO2009119982A2 Adamantine derivative for inhibiting toxicity of amyloid oligomer
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
10/01/2009WO2009119528A1 Heterocyclic compound
10/01/2009WO2009119088A1 Heterocyclic compound
10/01/2009WO2009118753A2 Process for preparation of naratriptan hydrochloride
10/01/2009WO2009118657A2 Polymorphic form of an aminoindan mesylate derivative
10/01/2009WO2009118655A2 Highly pure paliperidone or a pharmaceutically acceptable salt thereof substantially free of keto impurity
10/01/2009WO2009118516A1 Process for the preparation of donepezil hydrochloride
10/01/2009WO2009118473A2 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
10/01/2009WO2009118441A1 Use of pentacyclic triterpene for the preparation of a pharmaceutical compound intended for the treatment of multiple sclerosis
10/01/2009WO2009118338A2 Use of a polyphenolic type compound for preventing or treating a polyglutamine expansion neurodegenerative disease
10/01/2009WO2009118254A1 Aminopiperidinyl derivatives and uses thereof
10/01/2009WO2009118187A1 Methods for treating disorders using nmda nr2b-subtype selective antagonist
10/01/2009WO2009118175A1 Novel p2x7r antagonists and their use
10/01/2009WO2009118174A1 Substituted cyclohexyldiamines
10/01/2009WO2009118173A1 Substituted spirocyclic cyclohexane derivatives
10/01/2009WO2009118171A1 Hydroxymethylcyclohexyl amines
10/01/2009WO2009118169A1 Spiro(5.5)undecane derivatives
10/01/2009WO2009118168A1 Substituted 4-aminocyclohexane derivatives
10/01/2009WO2009118163A1 (hetero-)aryl cyclohexane derivatives
10/01/2009WO2009117985A1 Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases
10/01/2009WO2009117953A1 Pharmaceutical composition having antidepressive, antianxious action and preparation method thereof
10/01/2009WO2009117937A1 A pharmaceutical composition with the effects of hypnosis, anti-depression and anti-anxiety, and preparation thereof
10/01/2009WO2009117936A1 A pharmaceutical composition with effects of antipyretic, anti-inflammatory and analgesia and its preparation method
10/01/2009WO2009095454A3 Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients
10/01/2009WO2009094563A3 Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use
10/01/2009WO2009091964A3 Method for treating addiction using quercetin-containing compositions
10/01/2009WO2009090556A8 Artificial reproduction of pharmaceutical conditions of dependency to tobacco and other addictive drugs (opiacea, psychostimulants, alcohol) by combination of nicotine and a ligand (agonist or 5 antagonist) of 5-ht1a receptors
10/01/2009WO2009065922A3 Organic compounds
10/01/2009WO2009065919A3 Organic compounds
10/01/2009WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009WO2009033809A3 Use of a peptide as a therapeutic agent
10/01/2009WO2009033730A3 Peptide gxgrgdspca as a therapeutic agent
10/01/2009WO2009033666A3 Use of parathyroid hormone ( 1-34 ) as anti-hiv agent
10/01/2009US20090247741 Process for the production of multiple cross-linked hyaluronic acid derivatives
10/01/2009US20090247618 Process for preparation of benzo-fused heteroaryl derivatives
10/01/2009US20090247616 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
10/01/2009US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009US20090247593 N-thiazol-2-yl-benzamide derivatives
10/01/2009US20090247591 Substituted cyclohexyldiamines
10/01/2009US20090247587 1,3-dihydroisobenzofuran derivatives
10/01/2009US20090247585 Pharmaceutical composition comprising, in combination, saredutant and escitalopram
10/01/2009US20090247584 Phenoxy-piperidines for the treatment of diseases such as schizophrenia and depression
10/01/2009US20090247583 Pharmaceutical composition comprising, in combination, saredutant and paroxetine
10/01/2009US20090247573 (hetero)aryl cyclohexane derivatives
10/01/2009US20090247562 Large substituent, non-phenolic opioids and methods of use thereof
10/01/2009US20090247561 Substituted spirocyclic cyclohexane derivatives
10/01/2009US20090247560 Diaryl ketimine derivative
10/01/2009US20090247555 5,7-Disubstituted[1,3]Thiazolo[4,5-D]Pyrimidin-2(3H)-One Derivatives 258
10/01/2009US20090247553 Highly Pure Paliperidone or a Pharmaceutically Acceptable Salt Thereof Substantially Free of Keto Impurity
10/01/2009US20090247547 Hydroxamate-based inhibitors of deacetylases b
10/01/2009US20090247542 Syntheses and preparations of polymorphs of crystalline aripiprazole
10/01/2009US20090247536 Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of Use
10/01/2009US20090247535 Use of ranolazine for non-cardiovascular disorders
10/01/2009US20090247530 Substituted 4-aminocyclohexane derivatives
10/01/2009US20090247528 Method of treating attention deficit disorder
10/01/2009US20090247525 Sigma receptor inhibitors
10/01/2009US20090247514 Spirolactam aryl cgrp receptor antagonists
10/01/2009US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders
10/01/2009US20090247505 Spiro(5.5)undecane derivatives
10/01/2009US20090247504 Indazole Derivatives for Treatment of Alzheimer's Disease
10/01/2009US20090247501 Protein kinase inhibitors
10/01/2009US20090247500 Novel compounds as cannabinoid receptor ligands
10/01/2009US20090247498 Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications
10/01/2009US20090247492 Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
10/01/2009US20090247466 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
10/01/2009US20090247461 Methods for therapeutic treatment of pain
10/01/2009US20090247457 Neurotrophic components of the adnf i complex
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090247452 comprising ziconotide, methionine and hydromorphone for producing analgesia in a mammalian subject; reduces the side effects, no drug interactions
10/01/2009US20090246303 Method for Reducing The Effects of Chemotherapy Using Flagellin Related Polypeptides
10/01/2009US20090246300 Adaptogenic tea
10/01/2009US20090246284 O-desmethylvenlafaxine Cocrystals
10/01/2009US20090246269 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease
10/01/2009US20090246265 Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/01/2009US20090246215 Amyloid beta1-6 antigen arrays
1 ... 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 ... 1833